129 related articles for article (PubMed ID: 23156043)
1. [Hepatotropic therapy in treatment of liver injury].
Sukhanov DS; Okovityĭ SV; Iablonskiĭ PK; Vinogradova TI; Pavlova MV
Antibiot Khimioter; 2012; 57(5-6):41-52. PubMed ID: 23156043
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of hepatoprotective action of remaxol, reamberin and ademethionine in liver injury induced by antituberculosis drugs (experimental study)].
Sukhanov DS; Vinogradova TI; Zabolotnykh NV; Kovalenko AL; Vasil'eva SN; Romantsov MG
Antibiot Khimioter; 2011; 56(1-2):13-7. PubMed ID: 21780666
[TBL] [Abstract][Full Text] [Related]
3. [Hepatotropic medicines: current status].
Ter Arkh; 2012; 84(2):62-8. PubMed ID: 22715666
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of the hepatoprotective activity of reamberine, remaxol, and ademethionine and risk assessment in their use in patients with respiratory tuberculosis and drug-induced liver injury].
Sukhanov DS
Ter Arkh; 2012; 84(11):26-9. PubMed ID: 23252243
[TBL] [Abstract][Full Text] [Related]
5. [The hepatotropic activity of runihol and ademethionine against experimental liver damage caused by first-line antituberculosis drugs].
Sukhanov DS; Vinogradova TI; Zabolotnykh NV; Vitovskaia ML; Kovalenko AL
Arkh Patol; 2014; 76(2):26-30. PubMed ID: 25051722
[TBL] [Abstract][Full Text] [Related]
6. [The hepatoprotective activity of remaxol and S-adenosyl-L-methionine for liver damage caused by reserve-series antituberculosis drugs].
Sukhanov DS; Vinogradova TI; Zabolotnykh NV; Vasil'eva SN; Vitovskaia ML
Arkh Patol; 2013; 75(2):25-9. PubMed ID: 24006761
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study of cytoprotector effect of succinate-containing drugs on functional activity of liver].
Sukhanov DS; Kovalenko AL; Romantsov MG; Petrov AIu; Savateeva TN
Eksp Klin Farmakol; 2010 Aug; 73(8):35-8. PubMed ID: 20919557
[TBL] [Abstract][Full Text] [Related]
8. [Remaxol hepatoprotective therapy of patients with tuberculosis and HIV infection in day unit of tuberculosis dispensary].
Shevyreva EV; Ivanov AK; Sukhanov DS; Murzina AA
Antibiot Khimioter; 2012; 57(7-8):31-7. PubMed ID: 23350192
[TBL] [Abstract][Full Text] [Related]
9. [Induction of endogenous s-adenosyl-l-methionine in hepatocytes during pharmacological correction of experimental acute toxic and chronic drug-induced liver injury].
Sukhanov DS; Petrov AIu; Kovalenko AL; Romantsov MG
Eksp Klin Farmakol; 2011; 74(10):34-8. PubMed ID: 22238985
[TBL] [Abstract][Full Text] [Related]
10. [The efficacy of hepatotropic agent Remaxol in oncological patients with postoperative liver dysfunction].
Karelov AE; Pyshnaia IV; Mitrokhina MV; Popel' IV; Gorokhov LV; Kremzel' EG; Naperov EV; Nikolaev AA
Eksp Klin Farmakol; 2013; 76(7):19-23. PubMed ID: 24006611
[TBL] [Abstract][Full Text] [Related]
11. [Antioxidant properties of remaxol, reamberin, and ademetionine in patients with drug-induced liver injury on the background of antituberculous therapy].
Sukhanov DS
Eksp Klin Farmakol; 2013; 76(4):45-8. PubMed ID: 23762990
[TBL] [Abstract][Full Text] [Related]
12. Antituberculosis drugs and hepatotoxicity.
Yew WW; Leung CC
Respirology; 2006 Nov; 11(6):699-707. PubMed ID: 17052297
[TBL] [Abstract][Full Text] [Related]
13. [Correction of adverse reactions in antimicrobial therapy of respiratory tract tuberculosis].
Sukhanov DS; Kovalenko AL; Petrov AIu; Romantsov MG; Rybalkin SB
Antibiot Khimioter; 2008; 53(5-6):51-7. PubMed ID: 19069183
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacoeconomic Analysis of the Use of Hepatoprotectors in Management of Drug-Associated Liver Injury Due to Hodgkin's Lymphoma Chemotherapy].
Morikov DD; Morikova EG; Dvornichenko VV
Antibiot Khimioter; 2015; 60(7-8):23-6. PubMed ID: 26863739
[TBL] [Abstract][Full Text] [Related]
15. [Management of adverse effects with antituberculosis chemotherapy].
Tsuyuguchi K; Wada M
Kekkaku; 2011 Feb; 86(2):87-99. PubMed ID: 21404653
[TBL] [Abstract][Full Text] [Related]
16. Alcoholic hepatic impairment complicating treatment with hepatotoxic antituberculosis drugs.
Tiwari VK
J Indian Med Assoc; 1996 Sep; 94(9):347-8. PubMed ID: 9019083
[No Abstract] [Full Text] [Related]
17. Antituberculosis therapy drug-induced liver injury and acute liver failure.
Devarbhavi H; Dierkhising R; Kremers WK
Hepatology; 2010 Aug; 52(2):798-9; author reply 799-800. PubMed ID: 20683973
[No Abstract] [Full Text] [Related]
18. [Efficacy of galstena in liver damage induced by antitubercular agents].
Katikova OIu; Kostin IaV
Eksp Klin Farmakol; 2002; 65(2):64-6. PubMed ID: 12109299
[TBL] [Abstract][Full Text] [Related]
19. The dark side of antituberculosis therapy: adverse events involving liver function.
Schaberg T
Eur Respir J; 1995 Aug; 8(8):1247-9. PubMed ID: 7489784
[No Abstract] [Full Text] [Related]
20. [Comparative effectiveness hepatotropic activity remaxol and Essentiale N in chronic viral hepatitis].
Pavelkina VF; Ampleeva NP
Eksp Klin Farmakol; 2014; 77(12):17-21. PubMed ID: 25739188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
